Table 5.
Frequency and association of treatments provided.
| Variable | Total (n = 6 89) | Died (n = 103) | Discharged alive (n = 586) | p-value |
|---|---|---|---|---|
| Antibiotics (%)∗ | ||||
| Yes | 345 (100) | 58 (16.8) | 287 (83.2) | 0.170 |
| No | 344 (100) | 45 (13.1) | 299 (86.9) | |
| Antiviral treatment, n = 464 (%) | ||||
| Yes | 333 (100) | 31 (9.3) | 302 (90.7) | 0.487 |
| No | 131 (100) | 15 (11.5) | 116 (88.5) | |
| Remdesivir (%)∗ | ||||
| Yes | 92 (100) | 22 (23.9) | 70 (76.1) | 0.010∗ |
| No | 597 (100) | 81 (13.6) | 516 (86.4) | |
| Favipiravir (%)∗ | ||||
| Yes | 274 (100) | 16 (5.8) | 258 (94.2) | <0.001∗ |
| No | 415 (100) | 87 (21.0) | 328 (79.0) | |
| Corticosteroids (%)∗ | ||||
| Yes | 188 (100) | 41 (21.8) | 147 (78.1) | 0.002∗ |
| No | 501 (100) | 62 (12.4) | 439 (87.6) | |
| Anticoagulants, n = 466 (%)∗ | ||||
| Yes | 286 (100) | 43 (15.0) | 243 (85.0) | 0.958 |
| No | 403 (100) | 60 (14.9) | 343 (85.1) | |
| High-flow nasal cannula, n = 463 (%) | ||||
| Yes | 35 (100) | 7 (20.0) | 28 (80.0) | 0.045∗ |
| No | 428 (100) | 40 (9.3) | 388 (90.7) | |
| Invasive mechanical ventilation, n = 463 (%) | ||||
| Yes | 59 (100) | 18 (30.5) | 41 (69.5) | <0.001∗ |
| No | 630 (100) | 85 (13.5) | 545 (86.5) |
∗, Statistically significant (p-value <0.05).